Peptide Therapeutics Market Growth Accelerates: Strategic Forecast Predicts $74.98 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Peptide Therapeutics Industry Market Size Be by 2025?
Recently, there has been a significant increase in the size of the peptide therapeutics market. It is projected to rise from $45.15 billion in 2024 to $49.21 billion in 2025, registering a compound annual growth rate (CAGR) of 9.0%. The expansion during the historical period can be credited to a rise in chronic diseases, a deeper comprehension of molecular biology, and broader applications in the field of oncology.

What's the Long-Term Growth Forecast for the Peptide Therapeutics Market Size Through 2029?
Expectations for the peptide therapeutics market size indicate potential speedy expansion in the next few years. The market is predicted to reach $74.98 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.1%. The growth forecasted for this period is linked to an increased demand for personalized medicine, wider application in immunotherapy, improvements in peptide delivery systems, the rise of peptide targets in infectious diseases, and a heightened focus on rare diseases. Key trends during this period are anticipated to be technological progress in peptide synthesis, increased investment and funding, a heightened focus on peptide drug safety, market growth in emerging economies, and adopting artificial intelligence (AI).

View the full report here:
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

What Are the Key Growth Drivers Fueling the Peptide Therapeutics Market Expansion?
The forecasted rise in chronic diseases is predicted to fuel the expansion of the peptide therapeutics market. Chronic ailments are enduring illnesses that often cannot be completely cured but can occasionally be treated and managed. An escalation in chronic diseases can be attributed to factors such as increased usage of tobacco products, inadequate nutrition, physical inactivity, excessive alcohol consumption, among others. Peptide therapeutics can play a vital role in preventing and treating certain chronic conditions. For instance, the National Library of Medicine, a US-based institution, indicated in January 2023 that the number of US individuals aged 50 and above with at least one chronic ailment is set to rise by 99.5%, equivalent to 142.66 million, by 2050. Hence, the expected rise in chronic disease occurrence is anticipated to bolster the peptide therapeutics market throughout the projected period.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

What Trends Will Shape the Peptide Therapeutics Market Through 2029 and Beyond?
Predominant organizations in the peptide therapeutics market are striving to present innovative solutions, including the cell culture process, to acquire a competitive advantage in the sector. The cell culture process refers to the cultivation of cells outside their natural setting under specific controlled conditions, requiring the extraction of the cells from living tissues and maintaining them. For example, in June 2023, Evonik Industries AG, a German specialty chemical enterprise, unveiled cQrex KC. This is a novel peptide developed for biopharma applications that leverages the cell culture process in the creation of biological drugs. It facilitates cell culture process designers to enhance cystine supply and amplify cell culture productivity. cQrex KC aids in the advancements of vaccines, viral vectors, and cell therapies.

How Is the Peptide Therapeutics Market Segmented?
The peptide therapeutics market covered in this report is segmented -

1) By Type: Generic, Branded
2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal
3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

Subsegments:
1) By Generic: Generic Peptide Drugs, Biosimilars
2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7216&type=smp

Which Companies Are Leading the Charge in Peptide Therapeutics Market Innovation?
Major companies operating in the peptide therapeutics market include Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.

Which Regions Are Leading the Global Peptide Therapeutics Market in Revenue?
North America was the largest region in the peptide therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7216

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.